
Share
When Fairfield Medical Center's rescue deal drew regulatory scrutiny, the hospital found a different buyer. Federal officials say the switch shows struggling hospitals can't use financial distress as cover for deals that squeeze out competition.
For the people of southeastern Ohio, a hospital merger might sound like a story about spreadsheets and boardrooms. It isn't. It's a story about whether the emergency room down the road stays open, whether a maternity ward survives, and whether prices for a routine surgery climb because there's suddenly nowhere else to go. That's the backdrop against which federal regulators are now claiming a win in Fairfield County.
The 222-bed Fairfield Medical Center found itself at a crossroads. In late 2024, it signed a non-binding letter of intent to join OhioHealth, a sprawling 16-hospital system. Then, just months later, that plan quietly dissolved. This past week, Fairfield instead closed a deal with a smaller player, Adena Health, capping off what officials describe as a case study in how hospital mergers should unfold when a facility is under financial strain.
"Our responsibility has always been to ensure Fairfield Medical Center is positioned to serve our communities well into the future," said John R. "Jack" Janoso Jr., the hospital's president and CEO, in this week's announcement. "I believe joining Adena Health provides that strong path forward, and I am confident in all that is ahead."
The Federal Trade Commission wasted no time taking credit. In a Wednesday release, Chairman Andrew Ferguson said the agency, working alongside the Ohio Attorney General's Office, had investigated the original OhioHealth proposal and found it would have "threatened substantially to reduce competition among hospitals in this region, risking higher costs and diminished quality of care for patients across southeastern Ohio."
Think of it like a small town with two grocery stores. If they merge, the new combined store has no real competitor left. It can raise prices, cut back on services, or simply stop trying as hard, because customers have nowhere else to shop. Regulators worry the same dynamic plays out with hospitals, except the "products" are surgeries, emergency care, and sometimes life-or-death treatment.
According to the FTC, officials pushed Fairfield to widen its search rather than settle for the first offer on the table. That encouragement, the agency says, led the hospital to draw interest from multiple potential buyers before landing on Adena. The distinction mattered to regulators for a specific reason: Adena, unlike OhioHealth, didn't already operate a hospital in Fairfield County or the surrounding area. Its five-hospital footprint sits elsewhere in the state, meaning the merger wouldn't eliminate a nearby competitor.
FTC Bureau of Competition Director Daniel Guarnera framed the outcome as a template. "The Commission remains vigilant in preserving healthcare competition, especially when reviewing deals involving hospitals that serve rural communities," he said in a statement. "Today's announcement should serve as a reminder that we will stop bad hospital deals."

Ferguson's accompanying statement, released as a formal document, laid out both a warning and a rulebook. The warning: "financial distress is not a blank check for mergers" that harm competition. The rulebook draws from the FTC's Merger Guidelines and long-standing Supreme Court precedent, which allow a struggling hospital to claim what's called a "failing firm defense" only under narrow conditions. There must be a "grave probability of a business failure." The odds of a successful bankruptcy reorganization must be "dim or nonexistent." And the buyer must be the "only available purchaser" after a genuine, good-faith search for alternatives.
That last point cuts to the heart of the Fairfield case. "The mere fact, then, that a close competitor is willing to buy the financially distressed hospital is not sufficient to justify an otherwise unlawful risk of harm to patients and healthcare workers," Ferguson wrote. In plain terms: just because a nearby hospital system offers to buy you doesn't mean regulators will let that deal through, especially if a less competition-reducing option exists.
Ferguson's statement also spelled out how FTC staff evaluate whether a hospital's sale process passes muster. They look at whether the seller sought interest from a full range of potential buyers, whether those buyers had adequate time and information to make real offers, whether the seller negotiated in good faith, and whether offers from buyers who wouldn't raise competitive concerns were weighed appropriately. Ferguson noted these steps often serve the seller's own financial interests too, sometimes yielding better offers than a rushed sale to a handful of bidders. But the bottom line for regulators is firm: if a search turns up a buyer that preserves competition, the hospital can't walk away from that option simply because a rival's offer pays more.
Since closing the Fairfield deal, Adena now operates five hospitals and more than 50 locations spread across 11 counties in central and southern Ohio, employing roughly 6,000 people. Its financials tell the story of a modest but stable operation: $815 million in total revenue for fiscal year 2025, with a $7.2 million operating income, a 0.9% operating margin. That's a thin cushion, the kind many rural and community health systems operate on, but it's a cushion nonetheless.
OhioHealth's involvement in this saga doesn't end with the lost Fairfield deal. The nonprofit system has faced separate scrutiny this year. In February, the Ohio attorney general and the Department of Justice alleged that OhioHealth used its market power to force insurers into anticompetitive contracts. The system and government reached a settlement in June, though OhioHealth admitted no wrongdoing and continues to maintain that its contracting practices were, and remain, lawful.
Rural and community hospitals across the country are under real financial pressure, and many will face decisions like Fairfield's in the years ahead. The FTC's message here is straightforward: distress doesn't excuse deals that leave patients with fewer choices and higher prices. For families in places like Fairfield County, that principle isn't abstract. It's about whether the next hospital merger protects access to care, or quietly narrows it in the name of a quick rescue.
Tags
Original Sources
FTC claims Ohio hospital's acquisition pivot as antitrust victory
↗ https://www.fiercehealthcare.com/regulatory/ftc-claims-ohio-hospitals-acquisition-pivot-antitrust-victory
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
4 September 2026
24 articles
Related Articles

FDA Lets AI Medical Devices Reach Patients Before Full Approval Through New Pilot Program
Policy & Regulation · 6 min

Federal Audit Finds Medicare Part D Plans Paid $587.7 Million for Drugs That Should Have Been Over-the-Counter
Policy & Regulation · 5 min

Rep. Pallone Presses Arbitration Firms Over Rising No Surprises Act Dispute Costs
Policy & Regulation · 5 min
Related Articles

FDA Lets AI Medical Devices Reach Patients Before Full Approval Through New Pilot Program
Policy & Regulation · 6 min

Federal Audit Finds Medicare Part D Plans Paid $587.7 Million for Drugs That Should Have Been Over-the-Counter
Policy & Regulation · 5 min

Rep. Pallone Presses Arbitration Firms Over Rising No Surprises Act Dispute Costs
Policy & Regulation · 5 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.